Boston Sci Stent Development Proceeding In-House; J&J Velocity Moves Fast
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is pursuing the development of its next-generation coronary stent platform internally as well as with partner Medinol as a contingency to the ongoing uncertainties with the Israeli firm.